Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children

Neurosurgery

Volumn 68, Issue 3, 2011, Pages 588-600

  Cox Jr , Charles S ^a   Baumgartner, James E ^a   Harting, Matthew T ^a   Worth, Laura L ^c   Walker, Peter A ^a   Shah, Shinil K ^a   Ewing Cobbs, Linda ^a   Hasan, Khader M ^a,b   Day, Mary Clare ^a   Lee, Dean ^c   Jimenez, Fernando ^a   Gee, Adrian ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Cellular therapy; Clinical trial; Mononuclear cell; Pediatric; Stem cell; Traumatic brain injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD133 ANTIGEN; CD34 ANTIGEN; CREATININE; HEMOGLOBIN; LIVER ENZYME;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; DEPRESSION; DISABILITY; FEMALE; FUNCTIONAL ASSESSMENT; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; GRAY MATTER; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFUSION RELATED TOXICITY; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; LEUKOCYTE COUNT; LUNG FUNCTION TEST; LUNG INJURY; MALE; MONONUCLEAR CELL; MURRAY LUNG INJURY SCORE; NEUROMONITORING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PEDIATRIC LOGISTIC ORGAN DYSFUNCTION SCORE; PRIORITY JOURNAL; RESUSCITATION; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL; THROMBOCYTE COUNT; TOXICITY; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WHITE MATTER;

ADOLESCENT; BONE MARROW TRANSPLANTATION; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; TREATMENT OUTCOME;

EID: 79951774905     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318207734c     Document Type: Article

References (35)

1. Bowman SM, Bird TM, Aitken ME, Tilford JM. Trends in hospitalizations associated with pediatric traumatic brain injuries. Pediatrics. 2008;122(5):988-993.
2. Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med. 2008;358(23):2447-2456. (Pubitemid 351793018)
3. Adelson PD, Ragheb J, Kanev P, et al. Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children. Neurosurgery. 2005;56(4):740-754.
4. Berger MS, Pitts LH, Lovely M, Edwards MS, Bartkowski HM. Outcome from severe head injury in children and adolescents. J Neurosurg. 1985;62(2):194-199. (Pubitemid 15159945)
5. White JR, Farukhi Z, Bull C, et al. Predictors of outcome in severely head-injured children. Crit Care Med. 2001;29(3):534-540. (Pubitemid 32225294)
6. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma. 2002;19(5):503-557. (Pubitemid 34587299)
7. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276(5309):71-74. (Pubitemid 27161245)
8. Qu R, Li Y, Gao Q, et al. Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology. 2007;27(4):355-363. (Pubitemid 47063283)
9. Walker PA, Harting MT, Jimenez F, et al. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB mediated increase in Interleukin 6 (IL-6) production. Stem Cells Dev. 2010;19(6):967-976.
10. Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 19. The role of anti-seizure prophylaxis following severe pediatric traumatic brain injury. Pediatr Crit Care Med. 2003;4(3 suppl):S72-S75.
11. Walker PA, Harting MT, Baumgartner JE, Fletcher S, Strobel N, Cox CS Jr. Modern approaches to pediatric brain injury therapy. J Trauma. 2009;67(2 suppl):S120-S127.
12. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362(9379):192-197. (Pubitemid 36859934)
13. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720-723.
14. Hasan KM, Halphen C, Sankar A, et al. Diffusion tensor imaging-based tissue segmentation: validation and application to the developing child and adolescent brain. Neuroimage. 2007;34(4):1497-1505. (Pubitemid 46201906)
15. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14(1 pt 1):21-36. (Pubitemid 32552740)
16. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683-692.
17. Coyne TM, Marcus AJ, Woodbury D, Black IB. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells. 2006;24(11):2483- 2492. (Pubitemid 44674309)
18. Israelsson C, Bengtsson H, Kylberg A, et al. Distinct cellular patterns of upre-gulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma. 2008;25(8):959-974.
19. Walker PA, Shah SK, Harting MT, Cox CS, Jr. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech. 2009;2(1-2):23-38.
20. Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39(5):1569-1574.
21. Boltze J, Forschler A, Nitzsche B, et al. Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(12):1951-1964.
22. Wilde EA, Hunter JV, Newsome MR, et al. Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma. 2005;22(3):333-344. (Pubitemid 40434682)
23. Bendlin BB, Ries ML, Lazar M, et al. Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage. 2008;42(2):503-514.
24. Ewing-Cobbs L, Prasad MR, Swank P, et al. Arrested development and disrupted callosal microstructure following pediatric traumatic brain injury: relation to neurobehavioral outcomes. Neuroimage. 2008;42(4):1305-1315.
25. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003;100(3):1364-1369. (Pubitemid 36184007)
26. Harting MT, Baumgartner JE, Worth LL, et al. Cell therapies for traumatic brain injury. Neurosurg Focus. 2008;24(3-4):E18.
27. Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport. 2001;12(3):559-563. (Pubitemid 32173965)
28. Mahmood A, Lu D, Yi L, Chen JL, Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg. 2001;94(4):589-595. (Pubitemid 32799652)
29. Harting MT, Jimenez F, Xue H, et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg. 2009;110(6):1189-1197.
30. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS Jr. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery. 2008;144(5):803-813.
31. Chopp M, Li Y, Zhang ZG. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neuro-restorative cell-based therapies. Stroke. 2009;40(3 suppl):S143-S145.
32. Ohtaki H, Ylostalo JH, Foraker JE, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A. 2008;105(38):14638- 14643.
33. Willing AE, Pennypacker KR. Alternate approach to understanding the molecular mechanisms of stroke-induced injury. Histol Histopathol. 2007;22(6):697-701. (Pubitemid 46647281)
34. Lee ST, Chu K, Jung KH, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain. 2008;131(Pt 3): 616-629. (Pubitemid 351294711)
35. Fink DW Jr. FDA regulation of stem cell-based products. Science. 2009;324(5935):1662-1663.